PlainRecalls
FDA Drug Low Class III Terminated

Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-03.

Reported: April 9, 2014 Initiated: January 27, 2014 #D-1187-2014

Product Description

Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-03.

Reason for Recall

Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.

Details

Units Affected
5,172 bottles
Distribution
Nationwide
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-03.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 5,172 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 9, 2014. Severity: Low. Recall number: D-1187-2014.